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The aim of this study was to investigate the hepatoprotective effect of Matrine salvianolic acid B salt on carbon
tetrachloride (CCl4)-induced hepatic fibrosis in rats. Salvianolic acid B and Matrine has long been used to treat liver
fibrosis. Matrine salvianolic acid B salt is a new compound containing Salvianolic acid B and Matrine. Hepatic fibrosis
induced by CCl4 was studied in animal models using Wistar rats. Organ coefficient, serum aspartate
aminotransferase (AST), alanine aminotransferase (ALT), hexadecenoic acid (HA), laminin (LN), hydroxyproline (Hyp),
and glutathione (GSH), malondialdehyde (MDA), superoxide dismutase (SOD) in liver tissues were measured,
respectively. Histopathological changes in the livers were studied by hematoxylin-eosin (H&E) staining and Masson
Trichrome (MT) examination. The expression of transforming growth factor-β1 (TGF-β1) and α-smooth muscle actin
(α-SMA) was observed by immunohistochemical analysis. A significant reduction in serum levels of AST, ALT, HA, LN
and Hyp was observed in the Matrine salvianolic acid B salt treated groups, suggesting that the salt had
hepatoprotective effects. The depletion of GSH and SOD, as well as MDA accumulation in liver tissues was
suppressed by Matrine salvianolic acid B salt too. The expression of TGF-β1 and α-SMA measured by
immunohistology was significantly reduced by Matrine salvianolic acid B salt in a dose-dependent manner. Matrine
salvianolic acid B salt treatment attenuated the necro-inflammation and fibrogenesis induced by CCl4 injection, and
thus it is promising as a therapeutic anti-fibrotic agent against hepatic fibrosis.
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Hepatic fibrosis is a dynamic process characterized by
excessive deposition of extracellular matrix (ECM)
components, and can ultimately cause liver cirrhosis.
Activation of hepatic stellate cells (HSCs) is the key step
during the progress of hepatic fibrosis [1]. Upon activation
by liver injuries, HSCs transform into Myofibroblastic
cells which are proliferative and fibrogenic, with enhanced
production of ECM components including α-smooth
muscle actin (α-SMA), hexadecenoic acid (HA) and
laminin (LN) [2]. Generally, CCl4 is metabolized by micro-
somal monooxygenase system (cytochrome P450 2E1) to
its active metabolite, this process results in the fragmenta-
tion of the lipid peroxide radicals, lipid hydroperoxides* Correspondence: liguoyulisa@163.com; wjh.1972@yahoo.com.cn
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reproduction in any medium, provided the orand other products, each acting like an active oxidizing
agent [3-6]. Furthermore, these processes are immediately
followed by the infiltration of inflammatory cells and
release of various cytokines and growth factors [6]. Thus,
lipid peroxidation caused by free radicals of CCl4 metabol-
ism plays a vital role on the CCl4-induced liver injury [6,7].
In addition to lipid peroxidation, transforming growth
factor β1 (TGF-β1) is also an important activator of HSCs
in the course of hepatic fibrogenesis [3].Sophora flavescens ait
Has a wide range of pharmacological and toxicological
activities [8]. This herb has been used traditionally in
China against several pathophysiological states, such as
cancer, viral hepatitis, cardiac arrhythmia, and asthma [9].
Matrine is one of the most important alkaloids extracted
from this herb and it exerts a variety of pharmacological
effects, such as anti-inflammatory, immunoregulatory,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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years, Matrine has been used in the treatment of chronic
liver disease and has a significant effect on the inhibition
of liver fibrosis [12].
Salvia miltiorrhiza Bge
Is a well-known traditional Chinese herb which is
broadly planted in China. It has been used clinically for
the treatment of various diseases such as cardiovascular,
cerebrovascular, hyperlipidemia, and acute ischemic
stroke diseases [13] and has increasingly attracted the
attention of research groups in recent years especially in
biotechnological field. Salvianolic acid B (Sal-B) is one
of the water-soluble components of this herb. Previous
studies have shown that Salvianolic acid B is effective in
improving liver function, alleviating ischemic damage,
antioxidation, antihepatotoxicity and anticoagulation [14].
At present, the pharmacology activity of the salvianolic
acid B magnesium salt has been widely studied [15].
In order to obtain the cheap and highly efficient anti-
fibrosis drug, we adopted salvianolic acid B and Matrine
as raw materials to prepare Matrine salvianolic acid B
salt, which is first reported in this article. The structural
of Matrine salvianolic acid B salt has been confirmed by
the technique of TLC, UV, IR, NMR and TG-DSC.
Matrine salvianolic acid B salt has a good stability and
can overcome the shortcomings of salvianolic acid B and
Matrine [16]. Previous studies have shown its protective
effect against acute hepatotoxicity by reducing serum
AST and ALT levels induced by the treatment of CCl4,
Thioacetamide(TAA) and D-Galactosamine (D-GalN)
respectively in mice. The present study aimed to investi-
gate the protective effects of Matrine salvianolic acid B salt
on the liver fibrosis induced by CCl4. (Additional file 1).
Materials and methods
Drug material
Matrine (blanc needle crystal, >98%) was obtained from
Shan xi yi xing biological engineering limited company
(Shanxi, China). Salvianolic acid B (amber powder, >95%)
and Matrine salvianolic acid B salt (amber powder)
were prepared by ourself. The voucher specimen (No.
20070816066) is deposited in School of Pharmacy faculty,
Shihezi University.
Animals
Wistar Albino rats weighing between 180 and 250 g were
used with free access to food and water. Rats were
housed at room temperature with 12 h light/dark cycle.
The use of these animals was approved by the institute
ethnics committee of Shihezi University. The chronic
liver injury was induced by CCl4 injection as previously
described [5-7]. Rats were randomized into eight groups
(n = 12 in each group). The normal control group wasallowed free access to food and water; Liver injury was
performed in the remaining seven groups by i.p. 1.0 ml/kg
CCl4 and olive oil (2:3 v/v) mixture, twice in a week for
8 weeks. The rats of the remaining seven groups except
the model group were intragastric (i.g.) administrated
quantum satis (q.s.) dosages respectively (Matrine salvia-
nolic acid B salt group: 25 mg/kg, 50 mg/kg, 100 mg/kg
respectively; Matrine control group: 50 mg/kg; Salvianolic
acid B control group: 150 mg/kg; Positive control group:
780 mg/kg). Orally administration of different drugs were
performed at the day before CCl4 administration, and
applied once per day for 8 weeks.
Rats were sacrificed by cervical dislocation on the day
after the last intragastrical administration. Blood and liver
tissue samples were harvested for further examinations.
Serum was obtained by the centrifuge at 3,000 rpm for
10 min under 4°C, and stored at −20°C before use. Liver
tissues were collected for the measurements of glutathione
(GSH), malondialdehyde (MDA), superoxide dismutase
(SOD), as well as the histopathological changes.
Biochemical analysis
At 12 h after last intragastrical administration, rats were
killed. The blood sample were collected and then centri-
fuged at 3,000 rpm for 10 min at 4°C. Serum Aspartate
aminotransferase (AST) and Alanine aminotransferase
(ALT) were determined using Olympus kits (Olympus
Corp., Tokyo, Japan) in an Olympus AU 600 Autoanalyzer.
The observation absorbance of the reaction was read at
505 nm and the enzyme activity was calculated as U/L.
Serum Hexadecenoic acid (HA), Laminin (LN) and
Hydroxyproline (Hyp) levels were measured by the
enzyme-linked immunosorbent assay method using the
kit obtained from Sigma-Aldrich Chemicals Co., USA.
The observation absorbance of the reaction was read
at 450 nm.
Measurement of malondialdehyde (MDA) formation in
lipid peroxidation
Liver homogenate (10%, w/v) was prepared by homogen-
izing the liver tissue in 150 mM Tris–HCl buffered saline
(pH 7.2) with a polytron homogenizer. The level of
MDA in liver tissues was measured by following the
protocol provided by the kit from Jiancheng Biological
Engineering Institute (Nanjing, China).
Determination of antioxidant and antioxidant enzyme activity
SOD activity was determined by the commercial kit from
Jiancheng Biological Engineering Institute (Nanjing, China)
following the protocol provided by manufacture. Data are
expressed as SOD U/mg protein. The measurement of
GSH was conducted by modified protocol provided by
GSH kit from Jiancheng Biological Engineering Institute









Figure 1 The body weight of animals in the control, CCl4- and
drug-treated groups.
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was calculated as mg/g protein. The protein content was
measured by the methods of Lowry et al. (1951) with
bovine serum albumin as a standard.
Histopathological evaluation
Four-micrometer-thick sections obtained from paraffin
blocks were stained by hematoxylin-eosin (H&E) and
Masson trichrome (MT), and then examined with an
Olympus BX-50 microscope by × 40, ×100, ×200, and ×
400 magnifications. The histopathological evaluation was
performed by an expert pathologist blinded to the study
groups. The sections, stained with H&E, were examined
by light microscopy by × 200 magnification. In the sections
stained with MT, the central vein was focused, and the
images randomly taken from ten fields were evaluated
using image analysis, a specially designed software program
by × 200 magnification. The liver damage was graded as
following: _, absent; +, few; ++, mild and +++, moderate.
Hepatic fibrosis was graded according to the method of
Ruwart et al. (1989) [17] as the following: _, absent, normal
liver; +, few, increase of collagen without formation of
septa; ++, mild, formation of incomplete septa from portal
tract to central vein (septa that do not interconnect with
each other); and +++, moderate, complete but thin septa
interconnecting with each other (incomplete cirrhosis).
The final numerical score was calculated by dividing the
sum of the number per grade of affected rat by the total
number of examined rat.
Immunohistological analysis
The activation of HSCs was identified by immunohisto-
chemical analysis, staining by monoclonal α-SMA and
TGF-β1 antibody in deparaffinized tissue sections. Paraffin
section deparaffinage, use distilled water and 0.1 molL−1
PBS flush 5 min respectively; Then use 3% H2O2 incuba-
tion 10 min in room temperature, in order to deactivation
endogenous peroxydase; Use 0.1 molL−1 PBS flush 5 min,
three times, normo-goat serum 37°C blockage 30 min;
Dropwise 1:50 diluted primary antibody 4°C to stay over-
night, 0.1 molL–1 PBS flush 5 min, three times; Then
dropwise 1:100 diluted biotinylation goat anti-rabbit
secondary antibody, 37°C incubation 20 min; 0.1 molL−1
PBS flush 5 min, three times, dropwise SP, 37°C incubation
20 min; Use 0.1 molL−1 PBS flush 5 min, three times,
DAB colouration; Distilled water flush, termination
colouration; Hematoxylin counterstain; Gradient alcoholic
dehydration, dimethyl benzene transparent and neutro-
resin mounting. Observed under the microscope, the posi-
tive part shows Buffy.
Statistical analysis
All Data were expressed as Means ± Standard Deviations,
and analyzed with one-way analysis of variance (ANOVA).Statistical significance was analyzed by SPSS software
using LSD’s test.Results
The effect of Matrine salvianolic acid B salt on body
weight decreasing induced by CCl4 treatment
There was no significant difference among the mean
initial body weights of all groups (p< 0.05, Figure 1).
However, body weights of CCl4-and drug-treatment
groups were lower than that of the control group by the
end of the study (p< 0.05 for three doses of Matrine
salvianolic acid B salt group, Figure 1). And there was no
significant dose-respond relationship on the decreasing
of body weight among drug-treatment groups (p< 0.05,
Figure 1).The effect of Matrine salvianolic acid B salt on organ
coefficient increasing induced by CCl4 treatment
Organ coefficients including liver, spleen and kidney
coefficients were evaluated in rats. Similar to previous
studies [18], liver and spleen coefficients were signifi-
cantly increased in rats with CCl4-treatment (p< 0.01,
Table 1); In contrast, there is no difference in kidney
coefficient among all treated groups. As demonstrated in
Table 1, the increase of liver coefficient caused by CCl4
treatment in rats was reduced by Salvianolic acid B
(150 mg/kg), Matrine salvianolic acid B salt (25, 50, and
100 mg/kg), and Fu fang bie jia ruan gan pian treatment
(780 mg/kg) individually (p< 0.05, Table 1), expect for
Matrine treatment. Then the protective effect against the
increase of spleen coefficient was observed in rats with
Matrine (50 mg/kg), Matrine salvianolic acid B salt
(25, 50 and 100 mg/kg) and Fu fang bie jia ruan gan pian
treatment (780 mg/kg) (p< 0.01, Table 1), expect for
Salvianolic acid B treatment (150 mg/kg). Dose-effect
correlation was observed in Matrine salvianolic acid B
salt groups regarding to the increase of liver and spleen
coefficient by CCl4-treatment.
Table 1 Effect of Matrine salvianolic acid B salt on organ coefficient in hepotic fibrosis rats
Treatment Doses (mg/kg) Liver coefficient % Spleen coefficient % Kidney coefficient %
Normal control —— 2.55 ± 0.23 0.19 ± 0.05 0.73 ± 0.04
CCl4 —— 3.53 ± 0.37
## 0.27 ± 0.04## 0.71 ± 0.10
Matrine+ CCl4 50 3.33 ± 0.19 0.20 ± 0.03
** 0.75 ± 0.19
Salvianolic acid B+ CCl4 150 3.14 ± 0.55
* 0.26 ± 0.02 0.76 ± 0.16
25 3.18 ± 0.46* 0.21 ± 0.03** 0.73 ± 0.13
Matrine salvianolic acid B Salt+ CCl4 50 3.17 ± 0.26
* 0.20 ± 0.04** 0.71 ± 0.17
100 3.16 ± 0.49* 0.19 ± 0.05** 0.67 ± 0.12
Fu fang bie jia ruan gan pian+ CCl4 780 3.16 ± 0.35
* 0.20 ± 0.04** 0.72 ± 0.08
Data is expressed as the mean±SD (n = 12).
##p< 0.01 vs. the normal control group; *p< 0.05, **p< 0.01 vs. the CCl4-treated group.
Gao et al. Journal of Inflammation 2012, 9:16 Page 4 of 9
http://www.journal-inflammation.com/content/9/1/16The effect of Matrine salvianolic acid B salt on the
increase of serum AST and ALT in rats
There were dramatic increases of serum ALT and AST
after CCl4 treatment in rats, which were 4 and 6 times
higher compared to that of control group (p< 0.01,
Table 2). Consistent with previous studies [19], Fu fang bie
jia ruan gan pian treatment (780 mg/kg) showed a signifi-
cantly protective effect against the increase of serum ALT
and AST after long-term CCl4 injection in rats (p< 0.01,
Table 2). Similarly, Matrine (50 mg/kg) and Salvianolic
acid B treatment (150 mg/kg) decreased the elevation of
serum ALT and AST to the level relevant to that of Fu
fang bie jia ruan gan pian group after long-term CCl4
injection in rats (p< 0.01, Table 2). Furthermore, the
decrease of serum ALT and AST in rats treated with CCl4
was observed in Matrine salvianolic acid B salt groups
(25, 50 and 100 mg/kg), and the doses of Matrine salvianolic
acid B salt 100 mg/kg showed a significantly protective
effect (p< 0.01, Table 2).
The effect of Matrine salvianolic acid B salt on the
increase of serum HA, LN and Hyp in rats
After CCl4 admimistration, the levels of serum HA, LN
and Hyp were significantly increased, compared with





Salvianolic acid B+ CCl4 150
Matrine salvianolic acid B Salt+ CCl4 25
50
100
Fu fang bie jia ruan gan pian+ CCl4 780
Data is expressed as the mean±SD (n = 12).
##p< 0.01 vs. the normal control group; **p< 0.01 vs. the CCl4-treated group;
ap< 0.05, bp< 0.01 vs. the Matrine group; cp< 0.01 vs. the Salvianolic acid B group.treatment with Fu fang bie jia ruan gan pian (780 mg/kg)
significantly decreased the levels of serum LN and HyP
induced by CCl4 (p< 0.05, p< 0.01, Table 3), While there
is no significant difference between the levels of HA.
Meanwhile, Matrine (50 mg/kg) and Salvianolic acid B
treatment (150 mg/kg) markedly decreased the elevation
of serum HA, LN and HyP after long-term CCl4 injection
in rats (p< 0.05, p< 0.01, Table 3). In addition, except the
levels of LN in the group of 25 mg/kg Salt +CCl4, the levels
of serum HA, LN and Hyp were all lower in the Matrine
salvianolic acid B salt three doses group compared to
CCl4-treated group (p< 0.05, p< 0.01, Table 3). Moreover,
it has showed a good dose-effect relationship in various
doses of Matrine salvianolic acid B salt.
The effect of Matrine salvianolic acid B salt on liver tissue
GSH, MDA and SOD levels in rats
GSH and SOD could scavenge the lipid peroxide radicals,
lipid hydroperoxides and other products which is a toxic
metabolite of the CCl4. Therefore, we measured the
contents of GSH and SOD in liver tissue of rats. From
Table 4, we can clearly see the vast difference between
CCl4-treated group and the control group, the levels of
GSH and SOD were largely decreased (p< 0.01, Table 4)
in CCl4-treated group compared with that of controlLT in rats
AST (U/L) ALT (U/L)
45.59 ± 3.68 32.12 ± 14.09
211.20 ± 42.07## 221.24 ± 42.35##
142.87 ± 36.99** 138.87 ± 32.67**
104.22 ± 20.67** 154.92 ± 60.64**
159.10 ± 46.19** 169.92 ± 51.42**
119.80 ± 25.69** 144.33 ± 44.93**
102.49 ± 25.71**b 96.09 ± 27.28**ac
110.3 ± 26.62** 117.26 ± 40.70**
Table 3 Effect of Matrine salvianolic acid B salt on HA, LN and Hyp in rats
Treatment Doses (mg/kg) HA (ng/ml) LN (ng/ml) HyP (ng/ml)
Normal control —— 213.46 ± 21.62 85.39 ± 3.98 16.38 ± 1.30
CCl4 —— 328.71 ± 18.42
## 109.93 ± 18.16## 32.34 ± 6.41##
Matrine+ CCl4 50 292.49 ± 30.73
* 94.79 ± 19.24* 27.14 ± 1.58**
Salvianolic acid B+ CCl4 150 290.66 ± 53.77
* 88.36 ± 19.44** 22.25 ± 1.88**
25 289.88 ± 27.00* 99.79 ± 23.42 19.71 ± 1.52**bc
Matrine salvianolic acid B Salt+ CCl4 50 276.77 ± 47.19
** 85.61 ± 14.21** 19.14 ± 1.86**bd
100 264.70 ± 49.62** 81.61 ± 16.22**a 18.65 ± 1.94**bd
Fu fang bie jia ruan gan pian+ CCl4 780 299.76 ± 33.99 97.37 ± 15.35
* 18.86 ± 1.79**
Data is expressed as the mean±SD (n = 12).
##p< 0.01 vs. the normal control group; *p< 0.05, **p< 0.01 vs. the CCl4-treated group;
ap< 0.05, bp< 0.01 vs. the Matrine group; cp< 0.05, dp< 0.01 vs. the Salvianolic acid B group.
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treatment had significantly increased (p< 0.01, Table 4),
while there was no significant difference in the level of
SOD compared to the group of CCl4. After Salvianolic acid
B treatment, The levels of GSH and SOD were higher than
CCl4 treatment, but no significant difference. However,
treatment with Matrine salvianolic acid B salt (25, 50 and
100 mg/kg) significantly recovered the CCl4-induced GSH
and SOD depletion (p< 0.05, p< 0.01, Table 4). In
addition, CCl4 rats exhibited a significant increase in
hepatic MDA (a marker of lipid peroxidation levels)
(p< 0.01, Table 4), when compared with the control
group. On the other hand, treatment with Matrine salvia-
nolic acid B salt (25, 50 and 100 mg/kg) showed a signifi-
cant decrease in MDA levels with a dose-dependent
manner, to 2.58 ± 0.62, 2.11 ± 0.31 (p< 0.01, Table 4) and
1.79± 0.43 (p< 0.01, Table 4) respectively.
The effect of Matrine salvianolic acid B salt on
histopathological evaluation
In normal control group, liver sections showed normal
hepatic cells with well preserved cytoplasm, prominent
nucleolus and central vein (Figure 2a). The liver sections
of CCl4 treated group showed a moderate degree ofTable 4 Effect of Matrine salvianolic acid B salt on GSH, MDA
Treatment Doses (mg/kg) GSH (mg
Normal control —— 3.00 ± 0.14
CCl4 —— 1.85 ± 0.28
Matrine + CCl4 50 2.36 ± 0.53
Salvianolic acid B +CCl4 150 2.16 ± 0.65
25 2.28 ± 0.59
Matrine salvianolic acid B Salt + CCl4 50 2.48 ± 0.33
100 2.63 ± 0.29
Fu fang bie jia ruan gan pian +CCl4 780 2.52 ± 0.32
Data is expressed as the mean±SD (n = 12).
##p< 0.01 vs. the normal control group; *p< 0.05, **p< 0.01 vs. the CCl4-treated gro
ap< 0.01 vs. the Matrine group; bp< 0.05, cp< 0.01 vs. the Salvianolic acid B group.centrilobular necrosis, and mild degree of leukocytes
infiltration, bile duct proliferation, mitosis and calcification
(Figure 2b). The histological pattern of the livers treated
by Matrine salvianolic acid B salt showed a few to milder
degree of infiltration of leukocytes, absent to few degree of
necrosis, and bile duct proliferation (Figure 2e, f and g).
Similar trends were also observed in group of Fu fang bie
jia ruan gan pian (Figure 2h). The histological observations
also supported the results obtained from the serum
enzyme assay. Further, histopathological changes of fibro-
sis occurred in CCl4-intoxicated and prevention by the
treatment with Matrine salvianolic acid B salt are shown in
Figure 3 The livers of rat treated with CCl4 showed
extensive accumulation of connective tissue resulting in
formation of continuous fibrotic septa, nodules of regener-
ation, and noticeable alterations in the central vein as com-
pared to the normal control (Figure 3a and b). The group
treated with Matrine salvianolic acid B salt and Fu fang bie
jia ruan gan pian resulted in less pronounced destruction
of the liver architecture without fibrosis (Figure 3e, f, g
and h). According to microscopic examinations, severe
hepatic fibrosis induced by CCl4 was remarkably reduced
by the administration of Matrine salvianolic acid B salt,
which was in good correlation with the results of theand SOD in rats
/gprotein) MDA (nmol/mgprotein) SOD (U/mg protein)
1.03 ± 0.22 262.95 ± 30.43
## 3.00 ± 0.45## 151.95 ± 20.25##
** 2.52 ± 0.87 151.74 ± 11.44
2.12 ± 0.43** 159.85 ± 22.28
* 2.58 ± 0.62 169.94 ± 25.16
** 2.11 ± 0.31** 184.65 ± 24.90**ab
**b 1.79 ± 0.43**a 191.71 ± 48.32**ac
** 1.76 ± 0.76** 171.39 ± 28.90
up;
Figure 2 The H&E (×200) of the liver sections in rats. (a) Normal group; (b) CCl4-treated group; (c) Matrine +CCl4; (d) Salvianolic acid B +CCl4;
(e), (f) and (g) are Matrine salvianolic acid B salt group treated with 25, 50 and 100 mg/kg respectively; (h) Positive-drug+ CCl4.
Gao et al. Journal of Inflammation 2012, 9:16 Page 6 of 9
http://www.journal-inflammation.com/content/9/1/16serum aminotransferase activities and hepatic antioxidant
enzyme activities.The effect of Matrine salvianolic acid B salt on
immunohistochemistry analisis
Histological examination of livers from CCl4 rats revealed
the increase and expansion of fibrous septa, compared
with normal control rats. α-SMA and TGF-β1 expression
were more distinctly observed in the liver of CCl4 rats as
compared with normal control rats (Figure 4a, b and
Figure 5a, b). Treatment with Matrine salvianolic acid B
salt decreased α-SMA and TGF-β1 staining (Figure 4e, f, g
and Figure 5e, f, g). The fibrosis score in CCl4 rats was sig-
nificantly increased as compared to that of control rats,
and treatment of Matrine salvianolic acid B salt signifi-
cantly ameliorated hepatic fibrosis in CCl4 rats. Similarly,
protein components of α-SMA and TGF-β1 were signifi-
cantly down-regulated in the group of Matrine, Salvianolic
acid B and Fu fang bie jia ruan gan pian. Moreover, ascite
was detected in three rats from the CCl4-treated groupFigure 3 The MT examinations (×200) of the liver sections in rats. (a)
acid B + CCl4; (e), (f) and (g) are Matrine salvianolic acid B salt group treatedwith an odds ratio, while it was not observed in the other
groups (Figures 4 and 5).Discussion
CCI4-induced toxic liver injury which is a well characterized
model for hepatic fibrosis has been extensively performed
[5,6]. Hepatic fibrosis is a dynamic cascade beginning with
hepatocyte necrosis followed by the activation of the
inflammatory cells including macrophage, the activation
and proliferation of HSCs, and the release of fibrogenic
mediators [20]. AST and ALT are the aminotransferase in
liver cells. They are cytoplasmic in nature, but upon liver
injury these enzymes enter into the circulatory system due
to altered permeability of membrane. So the elevated
serum ALT and AST levels were indicative of hepatotox-
icity. In addition, excessive deposition of extracellular
matrix components such as collagen protein, proteoglycan
and osamine protein is also an important factor in liver
fibrosis. HA is an important composition of Connective
tissue matrix, which participate to form proteoglycan. HyPNormal group; (b) CCl4-treated group; (c) Matrine + CCl4; (d) Salvianolic
with 25, 50 and 100 mg/kg respectively; (h) Positive-drug+CCl4.
Figure 4 The immunohistochemical examination of α-SMA positive cells (×400) of the liver sections in rats. (a) Normal group; (b) CCl4
-treated group; (c) Matrine + CCl4; (d) Salvianolic acid B +CCl4; (e), (f) and (g) are Matrine salvianolic acid B salt group treated with 25, 50 and
100 mg/kg respectively; (h) Positive-drug+ CCl4.
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important index to appraisal hepatic fibrosis [21]. In our
present study, CCl4 caused a significant elevation of serum
levels of ALT and AST in rats, and pretreatment with
Matrine salvianolic acid B salt significantly attenuated the
increased activities of ALT and AST. Moreover, liver index
and levels of serum HA, LN, Hyp were increased in CCl4-
treated rats, and Matrine salvianolic acid B salt markedly
decreased the levels of serum HA, LN, Hyp and liver
index, suggesting its hepatoprotective effects. Histopatho-
logical observations further confirmed that liver injury
induced by CCl4 was largely prevented by pretreatment of
Matrine salvianolic acid B salt,for it has been demon-
strated that Matrine salvianolic acid B salt attenuates the
necro-inflammatory and fibrogenic effects of CCl4,
histopathologically.
CCI4 damages hepatocellular membrane via lipid peroxi-
dation, and this is followed by the release of inflammatory
mediators from the activated inflammatory cells which areFigure 5 The immunohistochemical examination of TGF-β1 positive ce
treated group; (c) Matrine + CCl4; (d) Salvianolic acid B + CCl4; (e), (f) and (g)
100 mg/kg respectively; (h) Positive-drug+ CCl4.thought to potentiate CCl4-induced hepatic injury [2,22].
In the present study, the level of lipid peroxide (MDA) in
liver tissue was increased and the activities of SOD and
GSH were diminished in the CCI4-treated rats. However,
pretreatment with Matrine salvianolic acid B salt reduced
the amount of MDA and increased the activities of
SOD and GSH. Together these evidences suggest that the
hepatoprotective effects of Matrine salvianolic acid B salt
might be in part due to ability to protect biomembrance
against the formation of lipid peroxidation.
It is well known that activation of HSCs plays a key role
in the pathogenesis of liver fibrosis [3,20]. In our study,
CCl4 enhanced expression of α-SMA, while the adminis-
tration of Matrine salvianolic acid B salt prevented the
development of fibrosis by inhibiting the activation of
HSCs, which has been supported by the reduction in the
activation of HSCs as seen by immunohistochemical stain-
ing of α-SMA. It has been reported that the activation of
HSCs is associated with the elevation of NF-κB activity,lls (×400) of the liver sections in rats. (a) Normal group; (b) CCl4-
are Matrine salvianolic acid B salt group treated with 25, 50 and
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http://www.journal-inflammation.com/content/9/1/16and it is well known that cytokines including TGF-β1
activate NF-κB signaling [23]. TGF-β1 is the most important
profibrotic cytokine, and it enhances the type I procollagen
synthesis [24,25]. Previous study reported that, proliferation
of fibroblast and production of collagen are enhanced by
growth factors such as TGF-β1. It has been reported that
anti-TGF-β1 antibody ameliorates concanavalin A-induced
hepatic fibrosis [26]. In our study, administration of Matrine
salvianolic acid B salt relatively reduced the increased levels
of TGF-β1 induced by CCl4 and therefore, it may be specu-
lated that the anti-fibrotic effect of Matrine salvianolic acid
B salt may be mediated by its suppressory effect on TGF-β1.
In conclusion, it seems that administration of Matrine
salvianolic acid B salt is effective in preventing necro-
inflammation and fibrogenesis in hepatic fibrosis induced
by CCl4. Moreover, Matrine salvianolic acid B salt is a
newly prepared compound. This complexes containing
one molecular of Salvianolic acid B and one molecular of
alkaloids (Matrine). In our study, we can also clearly see
the hepatoprotective effect of Matrine salvianolic acid B
salt is better than the two monomer componds, indicat-
ing Matrine salvianolic acid B salt might be a valuable
hepatoprotective agent.
The hepatoprotective effect of Matrine salvianolic acid B
salt treatment against CCl4-induced hepatic injury seems
to be related to the inhibition of lipid peroxidation and
levels of TGF-β1, the most important inflammatory medi-
ator. However, fibrogenesis may occur as a consequence of
an ongoing inflammatory process. Therefore, it is difficult
to speculate whether the attenuation of fibrosis by Matrine
salvianolic acid B salt is merely a reflection of direct effect
on fibrogenesis itself. Further experimental studies are
necessary to determine the role and mechanisms of
Matrine salvianolic acid B salt in the treatment of hepatic
fibrogenesis.Additional file
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